158 related articles for article (PubMed ID: 19695315)
21. Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of humanized monoclonal anti-IL-13 antibodies with different IL-13 neutralization mechanisms.
Vugmeyster Y; Szklut P; Tchistiakova L; Abraham W; Kasaian M; Xu X
Int Immunopharmacol; 2008 Mar; 8(3):477-83. PubMed ID: 18279802
[TBL] [Abstract][Full Text] [Related]
22. Characterization of glycidol-hemoglobin adducts as biomarkers of exposure and in vivo dose.
Honda H; Törnqvist M; Nishiyama N; Kasamatsu T
Toxicol Appl Pharmacol; 2014 Mar; 275(3):213-20. PubMed ID: 24467927
[TBL] [Abstract][Full Text] [Related]
23. A comparison of the pharmacokinetics of perfluorobutanesulfonate (PFBS) in rats, monkeys, and humans.
Olsen GW; Chang SC; Noker PE; Gorman GS; Ehresman DJ; Lieder PH; Butenhoff JL
Toxicology; 2009 Feb; 256(1-2):65-74. PubMed ID: 19059455
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic properties of TDP4815 after single intravenous and oral administrations to rat, rabbit, monkey, dog and in vitro drug metabolism.
Chen Y; Cheng D; Tio C; Kagan N; Eisennagel S; Dasgupta M; Tomczuk B; Bone R; Huebert N
Biopharm Drug Dispos; 2008 Apr; 29(3):127-38. PubMed ID: 18186144
[TBL] [Abstract][Full Text] [Related]
25. Adaptive response to low dose of EMS or MMS in human peripheral blood lymphocytes.
Harish SK; Guruprasad KP; Mahmood R; Vasudev V; Manjunath KR; Chethan GK
Indian J Exp Biol; 1998 Nov; 36(11):1147-50. PubMed ID: 10085785
[TBL] [Abstract][Full Text] [Related]
26. Cross-species comparison of in vivo PK/PD relationships for second-generation antisense oligonucleotides targeting apolipoprotein B-100.
Yu RZ; Lemonidis KM; Graham MJ; Matson JE; Crooke RM; Tribble DL; Wedel MK; Levin AA; Geary RS
Biochem Pharmacol; 2009 Mar; 77(5):910-9. PubMed ID: 19056355
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of the dipeptidyl peptidase 4 inhibitor saxagliptin in rats, dogs, and monkeys and clinical projections.
Fura A; Khanna A; Vyas V; Koplowitz B; Chang SY; Caporuscio C; Boulton DW; Christopher LJ; Chadwick KD; Hamann LG; Humphreys WG; Kirby M
Drug Metab Dispos; 2009 Jun; 37(6):1164-71. PubMed ID: 19251818
[TBL] [Abstract][Full Text] [Related]
28. Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches.
Hosea NA; Collard WT; Cole S; Maurer TS; Fang RX; Jones H; Kakar SM; Nakai Y; Smith BJ; Webster R; Beaumont K
J Clin Pharmacol; 2009 May; 49(5):513-33. PubMed ID: 19299532
[TBL] [Abstract][Full Text] [Related]
29. Preclinical pharmacokinetics and in vitro metabolism of brivanib (BMS-540215), a potent VEGFR2 inhibitor and its alanine ester prodrug brivanib alaninate.
Marathe PH; Kamath AV; Zhang Y; D'Arienzo C; Bhide R; Fargnoli J
Cancer Chemother Pharmacol; 2009 Dec; 65(1):55-66. PubMed ID: 19396600
[TBL] [Abstract][Full Text] [Related]
30. Lack of response to multiple genotoxic agents at the hprt locus in peripheral blood T-lymphocytes of cynomolgus monkeys.
Zimmer DM; Harbach PR; Mattano SS; Yu RL; Mattes WB; Aaron CS
Environ Mol Mutagen; 1999; 33(2):123-31. PubMed ID: 10217066
[TBL] [Abstract][Full Text] [Related]
31. Comparison of styrene-7,8-oxide adducts formed via reaction with cysteine, N-terminal valine and carboxylic acid residues in human, mouse and rat hemoglobin.
Yeowell-O'Connell K; Pauwels W; Severi M; Jin Z; Walker MR; Rappaport SM; Veulemans H
Chem Biol Interact; 1997 Aug; 106(1):67-85. PubMed ID: 9305409
[TBL] [Abstract][Full Text] [Related]
32. Ultrastructure of the seminiferous epithelium of ethyl methanesulphonate-treated mouse.
Gallegos-Avila G; Ortega-Martínez M; Ramírez-Bon E; Ancer-Rodríguez J; Jaramillo-Rangel G
Andrologia; 2007 Jun; 39(3):109-13. PubMed ID: 17683471
[TBL] [Abstract][Full Text] [Related]
33. Hemoglobin adducts in workers exposed to nitrotoluenes.
Jones CR; Liu YY; Sepai O; Yan H; Sabbioni G
Carcinogenesis; 2005 Jan; 26(1):133-43. PubMed ID: 15471893
[TBL] [Abstract][Full Text] [Related]
34. Disposition of GDC-0879, a B-RAF kinase inhibitor in preclinical species.
Choo EF; Driscoll JP; Feng J; Liederer B; Plise E; Randolph N; Shin Y; Wong S; Ran Y
Xenobiotica; 2009 Sep; 39(9):700-9. PubMed ID: 19552528
[TBL] [Abstract][Full Text] [Related]
35. DNA alkylation studies of combined treatment with methylnitrosourea and ethylmethanesulfonate in mice.
Platzek T; Bochert G
Teratog Carcinog Mutagen; 2000; 20(1):27-34. PubMed ID: 10607375
[TBL] [Abstract][Full Text] [Related]
36. Dosimetry of styrene 7,8-oxide in styrene- and styrene oxide-exposed mice and rats by quantification of haemoglobin adducts.
Osterman-Golkar S; Christakopoulos A; Zorcec V; Svensson K
Chem Biol Interact; 1995 Mar; 95(1-2):79-87. PubMed ID: 7697755
[TBL] [Abstract][Full Text] [Related]
37. Preclinical pharmacokinetics of a HepDirect prodrug of a novel phosphonate-containing thyroid hormone receptor agonist.
Fujitaki JM; Cable EE; Ito BR; Zhang BH; Hou J; Yang C; Bullough DA; Ferrero JL; van Poelje PD; Linemeyer DL; Erion MD
Drug Metab Dispos; 2008 Nov; 36(11):2393-403. PubMed ID: 18703645
[TBL] [Abstract][Full Text] [Related]
38. Acrylamide: a dietary carcinogen formed in vivo?
Tareke E; Lyn-Cook B; Robinson B; Ali SF
J Agric Food Chem; 2008 Aug; 56(15):6020-3. PubMed ID: 18624427
[TBL] [Abstract][Full Text] [Related]
39. Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens.
Doak SH; Jenkins GJ; Johnson GE; Quick E; Parry EM; Parry JM
Cancer Res; 2007 Apr; 67(8):3904-11. PubMed ID: 17440105
[TBL] [Abstract][Full Text] [Related]
40. [Biological effect of low doses of alkylating agents in drosophila studies].
Savina NV; Dalivelia OV; Nikitchenko NV; Kuzhir TD
Tsitol Genet; 2003; 37(1):48-55. PubMed ID: 12741062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
